Status:
UNKNOWN
Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD)
Lead Sponsor:
China Medical University Hospital
Conditions:
Gastroesophageal Reflux Disease
Eligibility:
All Genders
20-75 years
Phase:
PHASE4
Brief Summary
GERD is due to gastric content reflux to esophagus cause symptom and complication including intra-esophagus such as reflux esophagitis, and extra-esophagus such as cough etc. Because the changes of di...
Eligibility Criteria
Inclusion
- Gender:Male or female.
- Age: from 20 y/o to 75 y/o.
- The diagnosis is Gastroesophageal Reflux Disease.
- With the symptoms of heartburn or acid regurgitation.
- After explaining thoroughly the whole research purpose or process, the clients are willing to sign the agreement.
Exclusion
- Exclude peptic ulcer, gall bladder stone (including intraheptaic and common hepatical duct) and major diseased of cancer.
- Barrett's esophagus or esophagus stricture.
- The operation history of esophagus or gastroduodenoal regions.
- Tarry stool suspected GI tract bleeding.
- With the history of alcohol or drug abuse.
- The clients with the history of study drug allergy.
- The clients with psychologic cannot cooperate with each other.
- The pregnant woman or the lactating women.
- Abnormal liver function such as GOT, GPT elevated over double the normal range.
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT01822106
Start Date
February 1 2013
Last Update
April 2 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan